GSS 0.00% 76.0¢ genetic signatures limited

Ann: Quarterly update and Appendix 4C, page-11

  1. 119 Posts.
    lightbulb Created with Sketch. 11
    sorry should have written more details- what I meant was no FDA approval in site for another couple of months and that is probably the reason for selling / exiting this share. once fda is nearby then a takeover could be a possibility as well... I guess.
 
watchlist Created with Sketch. Add GSS (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.